Evidence map›Paper›PMID 37958213›Full record

ReviewDiagnostics (Basel, Switzerland)2023

Clinical and Paraclinical Characteristics of Endobronchial Pulmonary Squamous Cell Carcinoma-A Brief Review.

Radu Serban Matache, Camelia Stanciu-Gavan, Daniel Pantile, Adrian Mihail Iordache, Andreea Octavia Bejgăneanu, Crenguța Sorina Șerboiu, Alexandra Floriana Nemes

Open access · goldAbstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Imaging appearances, CT evolution patterns, and surgical prognosis of stage I lung squamous cell carcinoma.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Radu Serban MatacheDepartment of Thoracic Surgery, "Marius Nasta" Institute of Pneumophtiziology, 050159 Bucharest, Romania.ORCID 0009-0003-2334-9352
Camelia Stanciu-GavanDepartment of Thoracic Surgery, "Doctor Carol Davila" Central Military Emergency University Hospital, 010825 Bucharest, Romania.
Daniel PantileDepartment of Thoracic Surgery, "Doctor Carol Davila" Central Military Emergency University Hospital, 010825 Bucharest, Romania.
Adrian Mihail IordacheDepartment of Thoracic Surgery, "Doctor Carol Davila" Central Military Emergency University Hospital, 010825 Bucharest, Romania.
Andreea Octavia BejgăneanuLaboratory Department, Fundeni Clinical Hospital, 022328 Bucharest, Romania.
Crenguța Sorina ȘerboiuDepartment of Cellular, Molecular Biology and Histology, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Alexandra Floriana NemesDepartment of Neonatology, Louis Turcanu Clinical Emergency Hospital for Children, 300011 Timisoara, Romania.
Carol Davila University of Medicine and Pharmacy · ROInstitutul Clinic Fundeni · ROInstitutul de Pneumoftiziologie "Marius Nasta" · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEndobronchial squamous cell carcinoma is one of the most common types of tumors located inside the tracheobronchial tree. Patients often present in advanced stages of the disease, which most often leads to a targeted therapeutic attitude of pneumonectomy. Practicing lung parenchyma-preserving surgery led us to undertake this review. MATERIALS AND

methodsWe used three search platforms-SCIENCE, MEDLINE, and PubMed-in order to identify studies presenting case reports, investigations, and reviews on endobronchial squamous cell carcinoma. We identified the clinical and paraclinical features of endobronchial squamous cell carcinoma. All the selected articles were in English and addressed the clinical criteria of endobronchial squamous cell carcinoma, autofluorescence bronchoscopy in endobronchial squamous cell carcinoma, imaging features of endobronchial squamous cell carcinoma, blood tumor markers specific to lung squamous cell carcinoma, and histopathological features of endobronchial squamous cell carcinoma.

resultsIn total, 73 articles were analyzed, from which 48 articles were selected as bibliographic references. We present the criteria used for the identification of endobronchial squamous cell carcinoma in order to highlight its main characteristics and the most reliable technologies that can be used for the detection of this type of cancer.

conclusionsThe current literature review highlights the clinical and paraclinical characteristics of endobronchial squamous cell carcinoma. It aims to open new paths for research and early detection with respect to the frequent practice of lung parenchymal preservation surgery.

Indexed as

autofluorescence bronchoscopyendobronchial squamous cell carcinoma

Identifiers

PMID37958213
PMCPMC10647737
OpenAlexW4387957402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.